Press Releases | Health & Wellness Today New York

Explore more publications!

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE

Mar. 3, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ultragenyx Pharmaceutical Inc. of Class Action Lawsuit and Upcoming Deadlines – RARE

GlobeNewswire, Inc.

Mar. 3, 2026

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INO

GlobeNewswire, Inc.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI

Mar. 3, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI

GlobeNewswire, Inc.

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

Mar. 3, 2026

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO

GlobeNewswire, Inc.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT

Mar. 3, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardent Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDT

GlobeNewswire, Inc.

Karns & Karns Personal Injury and Accident Attorneys Launch Dual-Office Expansion into New York City and Brooklyn

Mar. 2, 2026

Karns & Karns Personal Injury and Accident Attorneys Launch Dual-Office Expansion into New York City and Brooklyn

EIN Presswire

Dual Restoration Highlights 2026 Flood Restoration Trends for Multi-Unit Building Flood Events Across NYC

Mar. 3, 2026

Dual Restoration Highlights 2026 Flood Restoration Trends for Multi-Unit Building Flood Events Across NYC

EIN Presswire

Better Health Labs, Inc. dba Measured - 721454 - 02/20/2026

Mar. 3, 2026

Better Health Labs, Inc. dba Measured - 721454 - 02/20/2026

U.S. Food and Drug Administration

Owner: American Government

U.S. Food and Drug Administration

Gov't Institution

Owned By	American Government through Department of Health and Human Services
Year Founded	1906
Website	www.fda.gov
Domain Registration Year	Indeterminate
Access Type	open
Publication Location	United States, Maryland, Silver Springs
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Just Salad and God’s Love We Deliver Introduce the Miso Mission Salad for National Nutrition Month

Mar. 3, 2026

Just Salad and God’s Love We Deliver Introduce the Miso Mission Salad for National Nutrition Month

GlobeNewswire, Inc.

Mount Sinai and King Saud University Medical City Forge a Three-Year Collaboration to Advance Precision Medicine in Familial Inflammatory Bowel Disease

Mar. 3, 2026

Mount Sinai and King Saud University Medical City Forge a Three-Year Collaboration to Advance Precision Medicine in Familial Inflammatory Bowel Disease

GlobeNewswire, Inc.

Mar. 3, 2026

LiveWorld Launches Integrated GEO, AIO and SEO Search Optimization for Healthcare and Pharma Brands

GlobeNewswire, Inc.

Mar. 3, 2026

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference

GlobeNewswire, Inc.

Mar. 3, 2026

National Healthcare Properties Announces $64 million SHOP Acquisition

GlobeNewswire, Inc.

Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease

Mar. 3, 2026

Prolium Bioscience Launches with $50 Million and Announces First Patients Dosed with PRO-203, a Potential Best-in-Class CD20xCD3 T-Cell Engager, for Severe Autoimmune Disease

GlobeNewswire, Inc.

The 'Biohack' for a Hyperactive Nervous System: Norwegian Tech to End 'Medical Gaslighting' for 4 Million Americans

Mar. 3, 2026

The 'Biohack' for a Hyperactive Nervous System: Norwegian Tech to End 'Medical Gaslighting' for 4 Million Americans

EIN Presswire

Mar. 3, 2026

Investor Reminder: Ardent Health Faces Federal Securities Fraud Allegations after Stock Drops 33% -- Contact BFA Law before March 9 Court Deadline (NYSE: ARDT)

GlobeNewswire, Inc.

ARDT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on April 21, 2026

Mar. 3, 2026

ARDT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Ardent Health (ARDT) Investors of Securities Class Action Deadline on April 21, 2026

GlobeNewswire, Inc.

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Mar. 3, 2026

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

GlobeNewswire, Inc.

Strata Critical Medical Announces Fourth Quarter 2025 Results

Mar. 3, 2026

Strata Critical Medical Announces Fourth Quarter 2025 Results

GlobeNewswire, Inc.

New York Art Life Magazine Releases Exclusive Feature: Out of the Wild Jonas Flanagan

Feb. 28, 2026

New York Art Life Magazine Releases Exclusive Feature: Out of the Wild Jonas Flanagan

EIN Presswire